SAT0186 Trends and correlates of erythropoiesis-stimulating agent use among patients with lupus nephritis reaching end-stage renal disease

J.A Gόmez-Puerta,W Winkelmayer,J Liu,S Waikar,K.H Costenbader

doi:10.1136/annrheumdis-2012-eular.3133

SAT0186 Trends and correlates of erythropoiesis-stimulating agent use among patients with lupus nephritis reaching end-stage renal disease

J.A Gόmez-Puerta, W Winkelmayer + Show 3 more

https://doi.org/10.1136/annrheumdis-2012-eular.3133

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2013

Affiliation: Stanford University, Brigham and Women's Hospital, Center for Rheumatology

#Erythropoiesis-stimulating Agents #Erythropoiesis-stimulating Agents Use + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundApproximately 20% of lupus nephritis (LN) patients develop end-stage renal disease (ESRD) within 10 years. As LN progresses, anemia is common. Little is known, however, about utilization patterns of erythropoiesis-stimulating...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.